Ultrasound-based Breast Cancer Screening in Chinese Women
1 other identifier
observational
20,000
1 country
16
Brief Summary
In the present study, the investigators will screen breast cancer of the Chinese women based on ultrasound and aim to compare the risk evaluation model of PUMCH model which was established by our previous work with other risk models.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2014
Longer than P75 for all trials
16 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 29, 2014
CompletedFirst Posted
Study publicly available on registry
October 20, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedOctober 20, 2014
October 1, 2014
2.9 years
September 29, 2014
October 15, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
number of cancer detected in the high-risk group
3 years
Study Arms (1)
group 1
ultrasound plus clinical breast examination
Interventions
all the participants will be required to fill risk factor questionaires and then be screened with ultrasound plus physical examination every year
Eligibility Criteria
healthy women without breast-related symptoms
You may qualify if:
- Written informed consent；
- residence from community or working units
You may not qualify if:
- pregnancy；
- lactation；
- known metastatic cancer；
- signs or symptoms of breast disease；
- presence of breast implants, breast surgery within prior 12 months；
- had mammography or ultrasound exam within prior 12 months
- males.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (16)
Peking Union Medical College Hospital
Beijing, Beijing Municipality, 100730, China
Beijing ChaoYang Hospital affiliated to the Capital Medical University
Beijing, Beijing Municipality, China
Beijing Hospital affiliated to Ministry of Health
Beijing, Beijing Municipality, China
First Hospital affiliated to Peking University
Beijing, Beijing Municipality, China
Southwest Hospital affiliated to the Third Military Medical University
Chongqing, Chongqing Municipality, China
ShanXi Traditional Medicine Hospital
Taiyuan, Shanxi, China
The Cancer Hospital affiliated to Tianjin Medical University
Tianjin, Tianjin Municipality, China
Chifeng Baoshan Hospital
Chifeng, China
First Affiliated Hospital of Chongqing Medical University
Chongqing, China
First People's Hospital of Honghe State
Mengzi, China
Ordos Central Hospital
Ordos, China
Qingdao Municipal Hospital
Qingdao, China
First Affiliated Hospital of China Medical University
Shenyang, China
Hospital of Xinjiang Production and Construction Corps
Ürümqi, China
Third Hospital of Xingtai
Xingtai, China
Yingshan Maternal and Child Health Hospital
Yingshan, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Sun Qiang, MD
PUMCH
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
September 29, 2014
First Posted
October 20, 2014
Study Start
January 1, 2014
Primary Completion
December 1, 2016
Study Completion
December 1, 2017
Last Updated
October 20, 2014
Record last verified: 2014-10